Key result
Younger COVID-19 autopsy cases show frequent pre-existing comorbidities alongside high rates of thromboembolism and ischemia.
Observational (n=6)
No
Answers are grounded in this paper and cite their sources.
OBJECTIVES: Studies on coronavirus disease 2019 (COVID-19) usually focus on middle-aged and older adults. However, younger patients may present with severe COVID-19 with potentially fatal outcomes. For optimized, more specialized therapeutic regimens in this particular patient group, a better understanding of the underlying pathomechanisms is of utmost importance. METHODS: Our study investigated relevant, pre-existing medical conditions, clinical histories, and autopsy findings, together with SARS-CoV-2-RNA, determined by qPCR, and laboratory data in six COVID-19 decedents aged 50 years or younger, who were autopsied at the Charité University Hospital. RESULTS: From a total of 76 COVID-19 patients who underwent an autopsy at our institution, six (7.9%) were 50 years old or younger. Most of these younger COVID-19 decedents presented with pre-existing medical conditions prior to SARS-CoV-2 infection. These included overweight and obesity, arterial hypertension, asthma, and obstructive sleep apnea, as well as graft-versus-host disease following cancer and bone marrow transplantation. Furthermore, clinical histories and autopsy results revealed a disproportionally high prevalence of thromboembolism and ischemic organ damage in this patient cohort. Histopathology and laboratory results indicated coagulopathies, signs of immune dysregulation, and liver damage. CONCLUSIONS: In conclusion, pre-existing health conditions may increase the risk of severe and fatal COVID-19 in younger patients, who may be especially prone to developing thromboembolic complications, immune dysregulation, and liver damage.
No takes yet. Share an insight, caveat, or question.
Greuel et al. (2021) conducted an observational in Fatal COVID-19 (n=6). SARS-CoV-2 infection and pre-existing medical conditions in young adults was evaluated on Autopsy findings, clinical histories, and laboratory results. Younger COVID-19 decedents frequently had pre-existing comorbidities and high prevalence of thromboembolism, coagulopathies, and ischemic organ damage.
Synapse has enriched 10 related papers. Consider them for comparative context: